Joshua B. Cohen, Co-Chief Executive Officer at Amylyx Pharmaceuticals, Inc. (AMLX), sold 42,980 shares at $3.47 ($149K) on 2025-03-31, disclosed to the SEC on 2025-04-02.
Open-market sale of $149k AMLX by Co-Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.47 | 21,490 | $75K | 50.0% |
| 2 | $3.47 | 21,490 | $75K | 50.0% |
| Total | $3.47 avg | 42,980 | $149K | 100% |
| Filing → |
| AMLX | SELL | 2026-02-04 | $228K | — | Filing → |
| AMLX | SELL | 2026-01-20 | $1.9M | — | Filing → |
| AMLX | SELL | 2026-01-08 | $86K | — | Filing → |